InvestorsObserver
×
News Home

Will CEL-SCI Corporation (CVM) Stay at the Top of the Healthcare Sector?

Friday, November 24, 2023 10:39 AM | InvestorsObserver Analysts

Mentioned in this article

Will CEL-SCI Corporation (CVM) Stay at the Top of the Healthcare Sector?

A rating of 93 puts CEL-SCI Corporation (CVM) near the top of the Healthcare sector according to InvestorsObserver. CEL-SCI Corporation's score of 93 means that it ranks higher than 93% of stocks in the sector. In addition, its overall score of 63 ranks it higher than 63% of all stocks.

Overall Score - 63
CVM has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on CVM!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With CEL-SCI Corporation Stock Today?

CEL-SCI Corporation (CVM) stock has gained 6.38% while the S&P 500 is down -0.01% as of 10:36 AM on Friday, Nov 24. CVM is higher by $0.15 from the previous closing price of $2.35 on volume of 182,635 shares. Over the past year the S&P 500 is higher by 13.17% while CVM is down -17.22%. CVM lost -$0.78 per share the over the last 12 months. Click Here to get the full Stock Report for CEL-SCI Corporation stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App